5,986 research outputs found
Stability of the proton-to-electron mass ratio
We report a limit on the fractional temporal variation of the
proton-to-electron mass ratio as, obtained by comparing the frequency of a
rovibrational transition in SF6 with the fundamental hyperfine transition in
Cs. The SF6 transition was accessed using a CO2 laser to interrogate spatial
2-photon Ramsey fringes. The atomic transition was accessed using a primary
standard controlled with a Cs fountain. This result is direct and model-free
Chemokines and the Tissue-Specific Migration of Lymphocytes
AbstractTissue-selective trafficking of memory and effector T and B lymphocytes is mediated by unique combinations of adhesion molecules and chemokines. The discovery of several related epithelial-expressed chemokines (TECK/CCL25 in small intestine, CTACK/CCL27 in skin, and MEC/CCL28 in diverse mucosal sites) now highlights an important role for epithelial cells in controlling homeostatic lymphocyte trafficking, including the localization of cutaneous and intestinal memory T cells, and of IgA plasma cells. Consitutively expressed epithelial chemokines may help determine the character of local immune responses and contribute to the systemic organization of the immune system
Rapid Acquisition of Tissue-specific Homing Phenotypes by CD4+ T Cells Activated in Cutaneous or Mucosal Lymphoid Tissues
Effector and memory T cells can be subdivided based on their ability to traffic through peripheral tissues such as inflamed skin and intestinal lamina propria, a property controlled by expression of ‘tissue-specific’ adhesion and chemoattractant receptors. However, little is known about the development of these selectively homing T cell subsets, and it is unclear whether activation in cutaneous versus intestinal lymphoid organs directly results in effector/memory T cells that differentially express adhesion and chemoattracant receptors targeting them to the corresponding nonlymphoid site. We define two murine CD4+ effector/memory T cell subsets that preferentially localize in cutaneous or intestinal lymphoid organs by their reciprocal expression of the adhesion molecules P-selectin ligand (P-lig) and α4β7, respectively. We show that within 2 d of systemic immunization CD4+ T cells activated in cutaneous lymph nodes upregulate P-lig, and downregulate α4β7, while those responding to antigen in intestinal lymph nodes selectively express high levels of α4β7 and acquire responsiveness to the intestinal chemokine thymus-expressed chemokine (TECK). Thus, during an immune response, local microenvironments within cutaneous and intestinal secondary lymphoid organs differentially direct T cell expression of these adhesion and chemoattractant receptors, targeting the resulting effector T cells to the inflamed skin or intestinal lamina propria
Multipole nonlinearity of metamaterials
We report on the linear and nonlinear optical response of metamaterials
evoked by first and second order multipoles. The analytical ground on which our
approach bases permits for new insights into the functionality of
metamaterials. For the sake of clarity we focus here on a key geometry, namely
the split-ring resonator, although the introduced formalism can be applied to
arbitrary structures. We derive the equations that describe linear and
nonlinear light propagation where special emphasis is put on second harmonic
generation. This contribution basically aims at stretching versatile and
existing concepts to describe light propagation in nonlinear media towards the
realm of metamaterials.Comment: 7 pages, 3 figure
Prior events predict cerebrovascular and coronary outcomes in the PROGRESS trial
<p><b>Background and Purpose:</b> The relationship between baseline and recurrent vascular events may be important in the targeting of secondary prevention strategies. We examined the relationship between initial event and various types of further vascular outcomes and associated effects of blood pressure (BP)–lowering.</p>
<p><b>Methods:</b> Subsidiary analyses of the Perindopril Protection Against Recurrent Stroke Study (PROGRESS) trial, a randomized, placebo-controlled trial that established the benefits of BP–lowering in 6105 patients (mean age 64 years, 30% female) with cerebrovascular disease, randomly assigned to either active treatment (perindopril for all, plus indapamide in those with neither an indication for, nor a contraindication to, a diuretic) or placebo(s).</p>
<p><b>Results:</b> Stroke subtypes and coronary events were associated with 1.5- to 6.6-fold greater risk of recurrence of the same event (hazard ratios, 1.51 to 6.64; P=0.1 for large artery infarction, P<0.0001 for other events). However, 46% to 92% of further vascular outcomes were not of the same type. Active treatment produced comparable reductions in the risk of vascular outcomes among patients with a broad range of vascular events at entry (relative risk reduction, 25%; P<0.0001 for ischemic stroke; 42%, P=0.0006 for hemorrhagic stroke; 17%, P=0.3 for coronary events; P homogeneity=0.4).</p>
<p><b>Conclusions:</b> Patients with previous vascular events are at high risk of recurrences of the same event. However, because they are also at risk of other vascular outcomes, a broad range of secondary prevention strategies is necessary for their treatment. BP–lowering is likely to be one of the most effective and generalizable strategies across a variety of major vascular events including stroke and myocardial infarction.</p>
Recommended from our members
Glacier-Linked Eskers on Mars: Environments of Recent Wet-Based Glaciation From Numerical Models
- …